Metilfenobarbitale [Dcit] en es it fr

Metilfenobarbitale [Dcit] Brand names, Metilfenobarbitale [Dcit] Analogs

Metilfenobarbitale [Dcit] Brand Names Mixture

  • No information avaliable

Metilfenobarbitale [Dcit] Chemical_Formula


Metilfenobarbitale [Dcit] RX_link

Metilfenobarbitale [Dcit] fda sheet

Metilfenobarbitale [Dcit] msds (material safety sheet)

Metilfenobarbitale [Dcit] Synthesis Reference

No information avaliable

Metilfenobarbitale [Dcit] Molecular Weight

246.262 g/mol

Metilfenobarbitale [Dcit] Melting Point

176 oC

Metilfenobarbitale [Dcit] H2O Solubility

Slightly soluble

Metilfenobarbitale [Dcit] State


Metilfenobarbitale [Dcit] LogP


Metilfenobarbitale [Dcit] Dosage Forms


Metilfenobarbitale [Dcit] Indication

For the relief of anxiety, tension, and apprehension, also used as an anticonvulsant for the treatment of epilepsy.

Metilfenobarbitale [Dcit] Pharmacology

R-mephobarbital, a barbiturate, is used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain. Barbiturates act as nonselective depressants of the central nervous system (CNS), capable of producing all levels of CNS mood alteration from excitation to mild sedation, hypnosis, and deep coma. In sufficiently high therapeutic doses, barbiturates induce anesthesia.

Metilfenobarbitale [Dcit] Absorption

Approximately 50% of an oral dose of mephobarbital is absorbed from the gastrointestinal tract.

Metilfenobarbitale [Dcit] side effects and Toxicity

No information avaliable

Metilfenobarbitale [Dcit] Patient Information

No information avaliable

Metilfenobarbitale [Dcit] Organisms Affected

Humans and other mammals